Demedarsp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2016-04-07
Share capital
5,000.00 PLN
Registered address
ul. Stanisława Leszczyńskiego 4, 50-078 Wrocław, Poland
Electronic delivery address
AE:PL-28611-80678-JDFHA-22

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 18 days early.

  • 2025filed
  • 202408/07/2025
  • 202311/07/2024
  • 202203/07/2023
  • 202118/06/2022
  • 202003/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Research and experimental development on biotechnology287 / 386
Top 74%
Division · Scientific research and development1,556 / 1,953
Top 80%
Sector · Professional, scientific and technical activities33,954 / 39,213
Top 87%
City · Wrocław12,197 / 13,702
Top 89%
Voivodeship · Dolnośląskie21,698 / 23,903
Top 91%
Country · Poland269,786 / 297,873
Top 91%

Results vs industry

Revenue
This companyUSD 3.88kMedianUSD 55.24kAverageUSD 2.70m
Net profit
This companyUSD -3.28kMedianUSD -1.27kAverageUSD -92.18k
Operating costs
This companyUSD 5.40kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 897.29MedianUSD 133.19kAverageUSD 3.03m

Industry

Authorized Representatives

Dariusz Jagielski – President of the Management Board
Ryszard Delikowski – Vice President of the Management Board

Manner of representation

To make declarations of will concerning the proprietary rights and obligations of the "company" and to sign contracts on behalf of the company, the following are authorised: in the case of a one-person management board, the President of the Management Board independently; in the case of a multi-member management board, the President of the Management Board or the Vice-President independently, or each member of the management board jointly with the President of the Management Board or the Vice-President. In the case of a multi-member management board, for judicial acts, making declarations on behalf of the company requires the joint action of two members of the management board or a member of the management board and a commercial proxy.

Ownership

OwnerSharesShare valueStake
Ryszard Delikowskiage 61
10$135.0610%
Dariusz Jagielskiage 59
79$1,066.9979%
Dariusz Smerekaage 57
10$135.0610%
Others
1$13.511%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2021-08-01.

  • mBank
    mBank
    16 1140 2004 0000 3602 8147 5739

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
Vitrotest Europesp. z o.o.
VASA Therapeuticssp. z o.o.
MultiqureS.A.
GenomtecS.A.
Bioselsp. z o.o.
InventroS.A.
Detoxedsp. z o.o.
ArthecS.A.
Centrum Transferu Technologii Meditransfer Iitdsp. z o.o.
Olenasp. z o.o.

FAQ

Last updated: 2026-04-17